Sort
21,281 grants matching “influenza”
Annual Estimates of Influenza Vaccine Effectiveness and Evaluation of Immune Response in a Wisconsin Population
$1,900,000Edward Belongia · Marshfield Clinic Research Foundation · U01 · FY2019 · IP
RFA-IP-22-004, Platform to Assess Influenza and COVID-19 Vaccine Effectiveness in Underserved Arizona Populations
$1,900,000Vel Murugan · Arizona State University-Tempe Campus · U01 · FY2024 · IP
Infectious Diseases Clinical Research Program
$1,900,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2010 · AI
Outpatient VE for seasonal flu, pandemic flu and RSV in a large, diverse network
$1,900,000Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2019 · IP
RFA-IP-22-004, Multidisciplinary Approach to Understanding Vaccine Efficacy and Transmission of Viral Respiratory Tract Infections in the Real World
$1,900,000Stacey House · Washington University · U01 · FY2023 · IP
RFA-IP-22-004, Evaluating respiratory virus vaccine effectiveness in a large, diverse healthcare system
$1,900,000Richard K Zimmerman · University Of Pittsburgh At Pittsburgh · U01 · FY2023 · IP
The Infectious Diseases Clinical Research Program (IDCRP)
$1,900,000National Institute Of Allergy And Infectious Diseases · Y01 · FY2013 · AI
5 YEAR STRATEGY FOR REDUCING MORBIDITY & MORTALITY CAUSED BY INFLUENZA
$1,899,628Caroline Brown · World Health Organization · U51 · FY2012 · IP
Kaiser Washington Vaccine and Treatment Evaluation Unit
$1,896,679Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2021 · AI
BASE AWARD
$1,896,671Gregory Sorenson · University Of Maryland Baltimore County · N01 · FY2023 · AI
Preclinical Studies of Vaccines for Pandemic Influenza
$1,896,554Kanta Subbarao · National Institute Of Allergy And Infectious Diseases · Z01 · FY2008 · AI
Center for Biomedical Research Excellence in Pathogen-Host Interactions
$1,895,489Stephen B Pruett · Mississippi State University · P20 · FY2016 · GM
CENTERS OF EXCELLENCE FOR INFLUENZA RESEARCH AND SURVEILLANCE (CEIRS)
$1,894,793Richard Webby · St. Jude Children'S Research Hospital · N01 · FY2019 · AI
Aging and Immunity to Infection
$1,893,300Laura Haynes · University Of Connecticut Sch Of Med/Dnt · P01 · FY2015 · AG
Membrane Remodeling in Viral Infection, Muscular Dystrophy, Parasite Invasion, and Traumatic Brain Injury
$1,892,942Joshua Zimmerberg · Eunice Kennedy Shriver National Institute Of Child Health & Human Development · ZIA · FY2016 · HD
Idaho Biomedical Research Collaborative in Emerging/Reemerging Infectious Disease
$1,891,500Dennis L Stevens · Idaho Veterans Research / Education Fdn · P20 · FY2017 · GM
Idaho Biomedical Research Collaborative in Emerging/Reemerging Infectious Disease
$1,891,500Dennis L Stevens · Idaho Veterans Research / Education Fdn · P20 · FY2020 · GM
Idaho Biomedical Research Collaborative in Emerging/Reemerging Infectious Disease
$1,891,500Dennis L Stevens · Idaho Veterans Research / Education Fdn · P20 · FY2019 · GM
Aging and Immunity to Infection
$1,890,558Laura Haynes · Trudeau Institute, Inc. · P01 · FY2012 · AG
Systems Approach to Immunity and Inflammation
$1,887,341Richard J Ulevitch · Scripps Research Institute, The · U19 · FY2021 · AI
Engineered Listeria monocytogenes as an AIDS vaccine
$1,886,912Immune Disease Institute, Inc. · P01 · FY2005 · AI
Center for Lung Biology and Disease
$1,886,626Samithamby Jeyaseelan · Louisiana State Univ A&M Col Baton Rouge · P20 · FY2022 · GM
Kaiser Washington Vaccine and Treatment Evaluation Unit
$1,884,389Lisa A Jackson · Kaiser Foundation Research Institute · UM1 · FY2020 · AI
Facility Management, Maintenance and Operations Core
$1,882,902Sixto Manuel Leal · University Of Alabama At Birmingham · UC7 · FY2024 · AI
Interferon-inducing compounds for use as broad antivirals/adjuvants
$1,881,355Peter Palese · Icahn School Of Medicine At Mount Sinai · N01 · FY2013 · AI